Medication

People with type 2 diabetes, especially young people, do not receive treatment for hypertension and dyslipidemia in a timely manner, even when they have high cardiovascular risk, study results show.

Canadian clinicians have reported the case of a woman on long-term rosuvastatin treatment who developed rhabdomyolysis within days of starting on canagliflozin.

Listen to our Editorial Board reflecting on their ADA scientific highlights, and its novel virtual format (34:17).

A major study shows that non-high-density lipoprotein levels predict atherosclerosis events over a 30-year timescale.

The potent lipid-lowering effects of the PCSK9 inhibitor evolocumab have been demonstrated in a randomized trial conducted specifically in people with type 2 diabetes.

A population-based study suggests that treatment with a statin may slow the risk for new and worsening retinopathy in patients with diabetes and dyslipidemia.

Type 2 diabetes and polyvascular disease are additive risk factors for cardiovascular events in patients with acute coronary syndromes, a secondary analysis of the IMPROVE-IT trial suggests.

Stoekenbroek RM et al. Nat Rev Endocrinol 2018. doi: 10.1038/s41574-018-0110-5

Ganda O. Curr Diab Rep 2018; 18: 126. doi: 10.1007/s11892-018-1087-0

Patti G et al. Nat Rev Cardiol 2018. doi: 10.1038/s41569-018-0080-2

van Stee MF, de Graaf AA, Groen AK. Cardiovasc Diabetol 2018; 17: 94. doi: 10.1186/s12933-018-0738-4

Strawbridge RJ, van Zuydam NR. Curr Diab Rep 2018; 18: 59. doi: 10.1007/s11892-018-1021-5

Blanc-Bisson C et al. Cardiovasc Diabetol 2018; 17: 82. doi: 10.1186/s12933-018-0718-8

Deng Z et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0448-7

Matsutani D et al. Cardiovasc Diabetol 2018; 17: 73. doi: 10.1186/s12933-018-0717-9

Wittemans LBL, Lotta LA, Langenberg C. Curr Diab Rep 2018; 18: 40. doi: 10.1007/s11892-018-1009-1

Owusu Adjah ES et al. Cardiovasc Diabetol 2018; 17: 70. doi: 10.1186/s12933-018-0712-1

Ginsberg HN et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0439-8

Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Lancet Diabetes Endocrinol 2018; Advance online publication. doi: 10.1016/S2213-8587(18)30079-2

Gant CM et al. Nutr Diabetes 2018; 8: 24. doi: 10.1038/s41387-018-0028-y